The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only.

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Decentralised Clinical Trials in Focus

Overcoming challenges to drive economic value in clinical development

Aired 26 September | Available On-demand

Presented by

In Partnership with

Overview

The advantages of decentralised clinical trials (DCTs) are generally recognised, especially the opportunity to make clinical trials more patient centric. Additional benefits are increasingly in evidence, such as improved patient recruitment, retention, and enhanced data quality. Nonetheless, there is a way to go before decentralised clinical trials are the standard rather than the optional model. Not surprisingly, technology and operational challenges appear to still be a stumbling block as sponsors get to grips with introducing new ways of working with sites and patients along with timeline demand in trials.

SEE FULL OVERVIEW

World-Class Business Leaders and Speakers. More to be confirmed.

Harpreet Gill

Head of Decentralised Clinical Trial Solutions

ICON plc

Jane Twitchen

Executive Director, Head, Clinical Trial Accelerator Unit

Biogen

Donato Paolo Mancini

Pharmaceuticals Correspondent

Financial Times

Angela May

Head DCT Strategy & Implementation, Clinical Operations

Bayer

Stephanie Manson Brown

Head of Clinical Development and Scientific Innovation, and Vice President

R&D Allergan Aesthetics at AbbVie

Financial value in DCTs

What is the underlying evidence for improved financial outcomes from DCTs when compared to conventional trials? How can economic/ financial value in DCTs be measured? Exploring the emerging metrics.

Technology and operational challenges

What are the types of technology and operational challenges sponsors are experiencing – are they teething problems or significant?

Experiences of clinical leaders

What have been the experiences of clinical/ development leaders in the last year? Where have they seen the benefits and value of DCTs emerging? How are they taking account of these in decision making?

SEE THE AGENDA

Aired on 26 September

FT Live Digital Dialogues - 50 minute experience delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.